Radionuclide Therapy for Skin Malignancies

  • Arthur Eung-Hyuk Cho
  • Min-Geol Lee
  • Jong Doo Lee
Part of the Medical Radiology book series (MEDRAD)


Skin cancer is the most common human malignancy. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) constitute approximately over 95 % (80 and 16 %, respectively) of new cases of non-melanoma skin cancers. It is estimated that over 1.3 million non-melanoma skin cancers will develop annually in the United States (Neville et al. 2007). Moreover, there are many conditions, especially actinic keratosis (AK) and Bowen’s disease, which can progress to invasive SCC. Treatment methods depend on the various clinical indications and histopathology of the malignancy. The three major therapeutic methods are topical application of chemotherapeutic agents, radiotherapy, and surgical management (Bolognia et al. 2003; Fitzpatrick et al. 2008). In this chapter, conventional therapeutic modalities for skin cancer managements will be briefly discussed and a new treatment modality using various beta-emitting radionuclides will be introduced.


Squamous Cell Carcinoma Basal Cell Carcinoma Actinic Keratosis Actinic Keratosis Lesion Superficial Basal Cell Carcinoma 


  1. Archambeau J, Pezner R, Wasserman T (1995) Pathophysiology of irradiated skin and breast. Int J Radiat Oncol, Biol, Phys 31(5):1171–1185CrossRefGoogle Scholar
  2. Avril MF, Auperin A, Margulis A et al (1997) Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 76(1):100–106PubMedCentralPubMedCrossRefGoogle Scholar
  3. Bladder H (1990) Subcellular localization of hematoporphyrin derivative in bladder tumor cells in culture. Photochem Photobiol 51(4):451–457CrossRefGoogle Scholar
  4. Bole P, HintzG P, Chan Y, Clauss R (1975) Bilateral carotid aneurysms secondary to radiation therapy. Ann Surg 181(6):888PubMedCentralPubMedCrossRefGoogle Scholar
  5. Bolognia J, Jorizzo J, Rapini R (2003) Dermatology. Mosby, LondonGoogle Scholar
  6. Calzavara-Pinton PG, Venturini M, Sala R (2007) Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol 21(3):293–302PubMedCrossRefGoogle Scholar
  7. Chung HS, Bang D, Lee JD, Sung YO, Park KB, Lee MG (1998) Treatment of multifocal Bowen’s disease with a specially designed radioactive skin patch. Br J Dermatol 139(5):938–939PubMedCrossRefGoogle Scholar
  8. Chung YL, Lee JD, Bang D, Lee JB, Park KB, Lee MG (2000) Treatment of Bowen’s disease with a specially designed radioactive skin patch. Eur J Nucl Med 27(7):842–846PubMedCrossRefGoogle Scholar
  9. Cox NH, Eedy DJ, Morton CA (2007) Guidelines for management of Bowen’s disease: 2006 update. Br J Dermatol 156(1):11–21PubMedCrossRefGoogle Scholar
  10. Cumberland L, Dana A, Liegeois N (2009) Mohs micrographic surgery for the management of nonmelanoma skin cancers. Facial Plast Surg Clin North Am 17(3):325–335PubMedCrossRefGoogle Scholar
  11. Datta SN, Loh CS, MacRobert AJ, Whatley SD, Matthews PN (1998) Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. Br J Cancer 78(8):1113–1118PubMedCentralPubMedCrossRefGoogle Scholar
  12. Dragieva G, Scharer L, Dummer R, Kempf W (2004) Photodynamic therapy—a new treatment option for epithelial malignancies of the skin. Onkologie 27(4):407–411PubMedCrossRefGoogle Scholar
  13. Drake LA, Dinehart SM, Goltz RW et al (1995) Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol 33(2 Pt 1):271–278Google Scholar
  14. Duncan KO, Leffell DJ (2003) Dermatology in general medicine, 6th edn. McGraw-Hill, New YorkGoogle Scholar
  15. Dupree MT, Kiteley RA, Weismantle K, Panos R, Johnstone PA (2001) Radiation therapy for Bowen’s disease: lessons for lesions of the lower extremity. J Am Acad Dermatol 45(3):401–404PubMedCrossRefGoogle Scholar
  16. Fitzpatrick T, Eisen A, Wolff K, Freedberg I, Austen K (2008) Dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  17. Geisse J, Rich P, Pandya A et al (2002) Imiquimod 5 % cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 47(3):390–398PubMedCrossRefGoogle Scholar
  18. Goldschmidt H, Panizzon R (1991) Modern dermatologic radiation therapy. Springer Verlag, New YorkCrossRefGoogle Scholar
  19. Hansen A, Hehrlein C, Hardt S et al (2001) Is the “candy-wrapper” effect of (32)P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasound. Catheter Cardiovasc Interv 54(1):41–48PubMedCrossRefGoogle Scholar
  20. Jeong JM, Chung JK (2003) Therapy with 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials. Cancer Biother Radiopharm 18(5):707–717PubMedCrossRefGoogle Scholar
  21. Jeong JM, Lee YJ, Kim EH et al (2003) Preparation of (188) Re-labeled paper for treating skin cancer. Appl Radiat Isot 58(5):551–555PubMedCrossRefGoogle Scholar
  22. Kay IP, Wardeh AJ, Kozuma K et al (2001) Radioactive stents delay but do not prevent in-stent neointimal hyperplasia. Circulation 103(1):14–17PubMedCrossRefGoogle Scholar
  23. Kim HS, Chan RC, Kollum M et al (2001) Effects of 32P radioactive stents on in-stent restenosis in a double stent injury model of the porcine coronary arteries. Int J Radiat Oncol Biol Phys 51(4):1058–1063PubMedCrossRefGoogle Scholar
  24. Lane JE, Kent DE (2005) Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery. Curr Surg 62(5):518–526PubMedCrossRefGoogle Scholar
  25. Lee JD, Park KK, Lee MG et al (1997) Radionuclide therapy of skin cancers and Bowen’s disease using a specially designed skin patch. J Nucl Med 38(5):697–702PubMedGoogle Scholar
  26. Liu Y, Liu JL, Cai ZZ et al (2007) A novel approach for treatment of unresectable pancreatic cancer: design of radioactive stents and trial studies on normal pigs. Clin Cancer Res 13(11):3326–3332PubMedCrossRefGoogle Scholar
  27. Liu Y, Liu JL, Cai ZZ et al (2009a) A novel approach for treatment of unresectable extrahepatic bile duct carcinoma: design of radioactive stents and an experimental trial in healthy pigs. Gastrointest Endosc 69(3 Pt 1):517–524PubMedCrossRefGoogle Scholar
  28. Liu Y, Lu Z, Zou DW et al (2009b) Intraluminal implantation of radioactive stents for treatment of primary carcinomas of the peripancreatic-head region: a pilot study. Gastrointest Endosc 69(6):1067–1073PubMedCrossRefGoogle Scholar
  29. Lovett RD, Perez CA, Shapiro SJ, Garcia DM (1990) External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 19(2):235–242PubMedCrossRefGoogle Scholar
  30. Marmur ES, Schmults CD, Goldberg DJ (2004) A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 30(2 Pt 2):264–271PubMedGoogle Scholar
  31. Minton TJ (2008) Contemporary Mohs surgery applications. Curr Opin Otolaryngol Head Neck Surg 16(4):376–380PubMedCrossRefGoogle Scholar
  32. Moloney FJ, Collins P (2007) Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 157(1):87–91PubMedCrossRefGoogle Scholar
  33. Morton CA, Brown SB, Collins S et al (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146(4):552–567PubMedCrossRefGoogle Scholar
  34. Mukherjee A, Pandey U, Sarma H, Pillai M, Venkatesh M (2002) Preparation and evaluation of 90Y skin patches for therapy of superficial tumours in mice. Nucl Med Commun 23(3):243PubMedCrossRefGoogle Scholar
  35. Mukherjee A, Pandey U, Sarma HD et al (2003) Bioevaluation of radioactive bandages in a murine model of melanoma. Int J Radiat Biol 79(10):839–845PubMedCrossRefGoogle Scholar
  36. Neville JA, Welch E, Leffell DJ (2007) Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 4(8):462–469PubMedCrossRefGoogle Scholar
  37. Orengo I, Rosen T, Guill CK (2002) Treatment of squamous cell carcinoma in situ of the penis with 5 % imiquimod cream: a case report. J Am Acad Dermatol 47(4 Suppl):S225–S228PubMedCrossRefGoogle Scholar
  38. Pandey U, Sarma HD, Ingle AD, Kulloli BS, Samuel G, Venkatesh M (2006) Radioactive skin bandages incorporating P-32 for treatment of superficial tumors. Cancer Biother Radiopharm 21(3):257–262PubMedCrossRefGoogle Scholar
  39. Pandey U, Saxena SK, Sarma HD et al (2008) Bioevaluation studies of 32P incorporated mould brachytherapy sources for potential application in treatment of superficial tumors. Nucl Med Commun 29(8):717–723PubMedCrossRefGoogle Scholar
  40. Pariser D, Lowe N, Stewart D et al (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48(2):227–232PubMedCrossRefGoogle Scholar
  41. Persaud AN, Shamuelova E, Sherer D et al (2002) Clinical effect of imiquimod 5 % cream in the treatment of actinic keratosis. J Am Acad Dermatol 47(4):553–556PubMedCrossRefGoogle Scholar
  42. Rajpar S, Marsden J (2008) ABC of skin cancer. Malden, Blackwell PublishingGoogle Scholar
  43. Rowe DE, Carroll RJ, Day CL Jr (1989a) Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 15(4):424–431PubMedCrossRefGoogle Scholar
  44. Rowe DE, Carroll RJ, Day CL Jr (1989b) Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15(3):315–328PubMedCrossRefGoogle Scholar
  45. Salgueiro MJ, Duran H, Palmieri M et al (2008a) Design and bioevaluation of a 32P-patch for brachytherapy of skin diseases. Appl Radiat Isot 66(3):303–309PubMedCrossRefGoogle Scholar
  46. Salgueiro MJ, Duran H, Palmieri M et al (2008b) Bioevaluation of 32P patch designed for the treatment of skin diseases. Nucl Med Biol 35(2):233–237PubMedCrossRefGoogle Scholar
  47. Salgueiro MJ, Collia N, Barreiro ML et al (2009a) Radioactive treatment of a murine melanoma using a (32)P-patch. Nucl Med Commun 30(9):706–712PubMedCrossRefGoogle Scholar
  48. Salgueiro MJ, Collia N, Duran H et al (2009b) Biological effects of brachytherapy using a (32)P-patch on the skin of Sencar mice. Appl Radiat Isot 67(10):1769–1774PubMedCrossRefGoogle Scholar
  49. Sandberg C, Stenquist B, Rosdahl I et al (2006) Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 86(5):404–408PubMedCrossRefGoogle Scholar
  50. Serruys PW, Kay IP (2000) I like the candy, I hate the wrapper: the (32)P radioactive stent. Circulation 101(1):3–7PubMedCrossRefGoogle Scholar
  51. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr (1998) Mohs micrographic surgery. J Am Acad Dermatol 39(1):79–97PubMedCrossRefGoogle Scholar
  52. Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ (1992) Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 18(7):549–554PubMedCrossRefGoogle Scholar
  53. Smeets NW, Kuijpers DI, Nelemans P et al (2004a) Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face—results of a retrospective study and review of the literature. Br J Dermatol 151(1):141–147PubMedCrossRefGoogle Scholar
  54. Smeets NW, Krekels GA, Ostertag JU et al (2004b) Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 364(9447):1766–1772PubMedCrossRefGoogle Scholar
  55. Snow SN, Madjar DD Jr (2001) Mohs surgery in the management of cutaneous malignancies. Clin Dermatol 19(3):339–347PubMedCrossRefGoogle Scholar
  56. Szeimies RM, Karrer S, Radakovic-Fijan S et al (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 47(2):258–262PubMedCrossRefGoogle Scholar
  57. Veness MJ (2008) The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. J Med Imaging Radiat Oncol 52(3):278–286PubMedCrossRefGoogle Scholar
  58. Vora SA, Garner SL (2004) Role of radiation therapy for facial skin cancers. Clin Plast Surg 31(1):33–38PubMedCrossRefGoogle Scholar
  59. Watanabe S, Osa A, Sekine T et al (1999) Production of radioactive endovascular stents by implantation of 133Xe ions. Appl Radiat Isot 51(2):197–202PubMedCrossRefGoogle Scholar
  60. Weinberger J, Amols H, Ennis R, Schwartz A, Wiedermann J, Marboe C (1996) Intracoronary irradiation: dose response for the prevention of restenosis in swine. Int J Radiat Oncol, Biol, Phys 36(4):767–775CrossRefGoogle Scholar
  61. Won JH, Lee JD, Wang HJ et al (2002) Self-expandable covered metallic esophageal stent impregnated with beta-emitting radionuclide: an experimental study in canine esophagus. Int J Radiat Oncol Biol Phys 53(4):1005–1013PubMedCrossRefGoogle Scholar
  62. Won JH, Lee JD, Wang HJ et al (2005) Effects of a holmium-166 incorporated covered stent placement in normal canine common bile ducts. J Vasc Interv Radiol 16(5):705–711PubMedCrossRefGoogle Scholar
  63. Zeitouni NC, Oseroff AR, Shieh S (2003) Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 39(17–18):1133–1136PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Arthur Eung-Hyuk Cho
    • 1
  • Min-Geol Lee
    • 2
  • Jong Doo Lee
    • 1
  1. 1.Department of Nuclear MedicineYonsei University College of MedicineSeoulKorea
  2. 2.Department of DermatologyYonsei University College of MedicineSeoulKorea

Personalised recommendations